ClinicalTrials.Veeva

Menu

Outcome of Transcatheter Closure of Patent Ductus Arteriosus in Pediatric Cardiology Unit in 3 Years Duration

A

Assiut University

Status

Not yet enrolling

Conditions

Patent Ductus Arteriosus (PDA)

Treatments

Procedure: transcatheter closure

Study type

Interventional

Funder types

Other

Identifiers

NCT06634407
Transcatheter closure of PDA

Details and patient eligibility

About

Transcatheter Closure of Patent Ductus Arteriosus to evaluate the outcome of percutaneous transcatheter closure of patent ductus arteriosus in children

Enrollment

90 estimated patients

Sex

All

Ages

6 months to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children with Patent Ductus Arteriosus confirmed by echocardiography
  • aged from 6 months to 16 years underwent percutaneous transcatheter PDA closure at Pediatric Cardiology Unit.

Exclusion criteria

  • Children with PDA younger than 6 months or older than 16 years and that are not candidate for transcatheter closure .

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

90 participants in 1 patient group

PDA patients
Other group
Treatment:
Procedure: transcatheter closure

Trial contacts and locations

0

Loading...

Central trial contact

Bassem Eldaba Fares bassem fares

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems